Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 25, 2026
Intel (INTC) Drops -30.5% in 30 Days Despite Strongest Revenue Growth in Years

Intel (INTC) Drops -30.5% in 30 Days Despite Strongest Revenue Growth in Years

Key Takeaways

  • Intel shares fell approximately 30.5% over the last 30 days, dropping from $132.87 on June 25 to $92.32 on July 24, 2026, erasing roughly $90 billion in market capitalization.
  • The decline occurred despite Intel reporting its strongest quarterly revenue growth in more than 15 years, with Q2 revenue of $16.1 billion up 25% year-over-year and EPS of $0.42 nearly doubling consensus estimates.
  • A broader rotation out of semiconductor and AI stocks has been the primary driver, with the Philadelphia Semiconductor Index declining about 14% in July amid mounting concerns over the sustainability of AI infrastructure spending.
  • Post-earnings price action proved particularly volatile: shares initially surged as much as 15% in after-hours trading following the Q2 report, only to reverse sharply and close down 7.9% the next day.
  • Valuation concerns, rising capital expenditure commitments exceeding $20 billion for 2026, and questions about foundry customer traction have compounded selling pressure despite improving fundamentals.

Intel Corporation (INTC) Overview and Market Position

Intel Corporation is one of the world's largest semiconductor manufacturers, designing and fabricating microprocessors, chipsets, and related components that power personal computers, data centers, networking equipment, and embedded systems. The company pioneered the x86 architecture and remains a dominant force in the CPU market through its Core and Xeon processor families. Under CEO Lip-Bu Tan, Intel has aggressively expanded into the foundry business, manufacturing chips for external customers as part of a broader turnaround strategy aimed at reclaiming technology leadership. The company's unique position as America's only advanced logic chip manufacturer, supported by $8.5 billion in CHIPS Act subsidies, gives it a structural advantage that global competitors cannot easily replicate. With a market capitalization of roughly $464 billion and its stock up over 150% year-to-date despite recent selling, INTC remains one of the most closely watched names in the semiconductor industry. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

INTC Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, Intel shares have experienced a sharp correction, declining approximately 30.5% from a close of $132.87 on June 25 to $92.32 on July 24. This selloff erased nearly $90 billion in market value and placed INTC among the weakest performers in the S&P 500 for the month of July. Trading volume surged well above the three-month average during the most volatile sessions, reflecting elevated institutional repositioning and options activity.

The broader quarterly picture tells a more nuanced story. From late April, when shares traded near $85, Intel staged a powerful rally that carried the stock to an all-time closing high of $140.94 by June 22 — a gain of roughly 66% in under two months. However, the subsequent 30-day decline wiped out the majority of those gains, leaving the stock up approximately 8.6% over the full quarterly period. The extreme round-trip underscores how sentiment-driven momentum, rather than fundamental deterioration, has dictated recent price action.

What Drove the Recent 30-Day Decline in INTC Shares

The primary catalyst behind Intel's 30-day decline has been a broad-based rotation out of semiconductor and AI-related equities. The Philadelphia Semiconductor Index fell roughly 14% in July, briefly entering bear-market territory, as investors grew increasingly skeptical about the pace and sustainability of AI capital expenditure. Even strong earnings from Taiwan Semiconductor Manufacturing Co. failed to lift the sector, signaling that elevated expectations had already been priced into chip stocks.

Intel's own Q2 earnings report, released after the market close on July 23, exemplified this dynamic. The company delivered revenue of $16.1 billion — its fastest growth in over 15 years — along with EPS of $0.42, nearly double the $0.21 consensus. Data center and AI revenue surged 59% year-over-year to $6.3 billion, while the foundry segment grew 31% to $5.8 billion. The stock initially rallied as much as 15% in after-hours trading. Yet by the close on July 24, shares had reversed entirely, finishing down 7.89% on the day as investors refocused on concerns about foundry customer concentration, rising capital expenditures now projected above $20 billion for 2026, and potential equity dilution to fund expansion. From what I see, valuation has also emerged as a significant headwind. At its June peak, INTC traded at approximately 74 times forward earnings, compared with a 10-year historical average of 22 times and well above peers such as NVIDIA and Broadcom. Several analysts, including Mizuho and Cantor Fitzgerald, lowered price targets following the earnings report, citing margin headwinds and longer-term foundry execution risk. Rising Treasury yields and renewed geopolitical tensions added further pressure, reinforcing a risk-off posture that disproportionately affected high-momentum names like Intel.

Factors Behind INTC Stock Performance Over the Last Quarter

Intel's quarterly performance was defined by a powerful rally that reflected genuine operational improvement before sentiment abruptly shifted. The stock nearly doubled from its late-April levels, driven by a series of transformative developments: the announcement of a foundry partnership with Tesla for Elon Musk's Terafab AI chip project, reports that Apple had agreed to manufacture processors at Intel's U.S. facilities, and confirmation that the 18A process node had entered risk production on schedule. The company also committed to high-volume manufacturing on its most advanced 14A process by 2028, dispelling earlier doubts about whether it would proceed with the cutting-edge node. These catalysts coincided with a broader market realization that agentic AI — the shift from training large language models to deploying autonomous AI agents at scale — was driving unprecedented demand for server CPUs, Intel's core franchise. The narrative that CPU architecture would play a central role in the next phase of AI infrastructure buildout propelled Intel shares alongside other semiconductor leaders. However, the same momentum-driven exuberance that fueled the rally set the stage for the subsequent correction, as frothy valuations and sector-wide fatigue ultimately triggered a sharp reversion.

INTC Stock Forecast Drivers: What Investors Should Watch Next

Looking ahead, several factors will be critical in determining Intel's trajectory. The company's ability to convert its CPU supply shortage into sustained, profitable revenue growth remains the central question. Management has disclosed 10 long-term supply agreements with server customers, which should improve revenue visibility, but execution on ramping production capacity will be closely scrutinized. Progress on securing additional external foundry customers — beyond the Tesla partnership — will serve as a key test of the foundry strategy's commercial viability. On the macroeconomic front, investors should monitor Federal Reserve policy signals and Treasury yield movements, as higher rates tend to compress valuations for high-multiple growth stocks like Intel. The broader AI spending cycle also warrants attention: if enterprise adoption of agentic AI accelerates through year-end, Intel's data center segment could deliver upside relative to already-elevated expectations. Conversely, any signs that hyperscaler capex growth is plateauing would likely weigh on the entire semiconductor complex. Intel's Q3 guidance of $16.3 billion in revenue at the midpoint, along with its projected sequential gross margin improvement to approximately 42%, provides a near-term benchmark against which the market will measure ongoing execution. I’m watching this closely as execution on these fronts will likely dictate whether the recent correction proves temporary.

Using AI Tools in Volatile Semiconductor Markets

When navigating swings in the semiconductor sector, I often turn to Tickeron’s Trending AI Robots for ideas on automated strategies. These AI-powered bots cover approaches from short-term momentum to longer swing and trend-following methods, with only top performers highlighted to help cut through the noise. Exploring this resource has been a useful starting point for incorporating data-driven tools into my process.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: INTC

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


INTC in +14.05% Uptrend, rising for three consecutive days on September 22, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where INTC advanced for three days, in 226 of 310 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

INTC moved above its 50-day moving average on September 16, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for INTC crossed bullishly above the 50-day moving average on September 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.

The Aroon Indicator entered an Uptrend today. In 117 of 174 cases where INTC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.

Bearish Trend Analysis

The 10-day RSI Indicator for INTC moved out of overbought territory on September 25, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 26 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 60 cases where INTC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.

The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INTC as a result. In 73 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

The Moving Average Convergence Divergence Histogram (MACD) for INTC turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 27 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INTC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.

INTC broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. INTC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 43 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.008) is normal, around the industry mean (7.902). INTC's P/E Ratio (904.167) is considerably higher than the industry average of (163.223). Projected Growth (PEG Ratio) (1.359) is also within normal values, averaging (3.705). Dividend Yield (0.004) settles around the average of (0.007) among similar stocks. P/S Ratio (8.696) is also within normal values, averaging (45.163).

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM), Analog Devices (NASDAQ:ADI).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 216.18B. The market cap for tickers in the group ranges from 86.8K to 5.53T. NVDA holds the highest valuation in this group at 5.53T. The lowest valued company is STRB at 86.8K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 4%. For the same Industry, the average monthly price growth was 11%, and the average quarterly price growth was 52%. WOLF experienced the highest price growth at 22%, while MOBX experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was 5%. For the same stocks of the Industry, the average monthly volume growth was -0% and the average quarterly volume growth was -57%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 51
Price Growth Rating: 41
SMR Rating: 72
Profit Risk Rating: 71
Seasonality Score: 20 (-100 ... +100)
View a ticker or compare two or three
INTC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of computer components and related products

Industry Semiconductors

Industry
Semiconductors
Address
2200 Mission College Boulevard
Phone
+1 408 765-8080
Employees
85100
Web
https://www.intel.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.